About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc (TMO) is a Healthcare company in the Measuring & Controlling Devices, NEC industry with a market capitalisation of $226.2B. The stock trades at 32.80x trailing earnings and yields 0.3%.
- Sector
- Healthcare
- Industry
- Measuring & Controlling Devices, NEC
- Market cap
- $226.2B
- P/E ratio
- 32.80
- EPS (TTM)
- $17.74
- Revenue (TTM)
- $44.6B
- Free cash flow
- $6.3B
- Profit margin
- 15.1%
- Dividend yield
- 0.3%
- Shares outstanding
- 369.7M
Financial health: Strong7.5/10
5 strengths, 0 concerns. No red flags against these benchmarks.
- Debt to equity: 0.73 (Watch, benchmark < 0.5) — Debt of 0.73x equity is moderate against the 0.5x benchmark. It has been broadly flat over the last 4 years.
- Net debt vs cash flow: 4.6y (Watch, benchmark < 4 years) — Net debt of $29.1B is 4.6x annual free cash flow — about 5 years of cash flow to repay.
- Current ratio: 1.89 (Strong, benchmark > 1.5) — Short-term assets cover 1.89x short-term liabilities, against Graham's 1.5x floor. It has improved over the last 4 years.
- Return on equity: 12.6% (Watch, benchmark > 15%) — Earns 12.6% on shareholder equity, short of the > 15% mark.
- Gross margin: 40.8% (Strong, benchmark > 40%) — Keeps 40.8% of revenue after the direct cost of sales, comfortably past the > 40% mark.
- Net margin: 15.1% (Strong, benchmark > 10%) — Turns 15.1% of revenue into profit, comfortably past the > 10% mark.
- Free cash flow: $6.3B (Strong, benchmark positive) — Generated $6.3B of free cash flow after capital spending. It has been broadly flat over the last 4 years.
- Revenue growth: 3.9% (Watch, benchmark > 10%) — Revenue changed 3.9% year on year, short of the > 10% mark.
- Earnings growth: 6.0% (Watch, benchmark > 10%) — Earnings changed 6.0% year on year, short of the > 10% mark.
- Payout ratio: 9.5% (Strong, benchmark < 60%) — Pays out 9.5% of earnings as dividends, leaving room to keep paying.